Logo image of IMMR

IMMERSION CORPORATION (IMMR) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:IMMR - US4525211078 - Common Stock

6.82 USD
+0.01 (+0.15%)
Last: 12/5/2025, 8:00:01 PM
6.82 USD
0 (0%)
After Hours: 12/5/2025, 8:00:01 PM
Fundamental Rating

5

Taking everything into account, IMMR scores 5 out of 10 in our fundamental rating. IMMR was compared to 35 industry peers in the Technology Hardware, Storage & Peripherals industry. IMMR has a medium profitability rating, but doesn't score so well on its financial health evaluation. IMMR scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year IMMR was profitable.
Of the past 5 years IMMR 4 years were profitable.
Of the past 5 years IMMR 4 years had a positive operating cash flow.
IMMR Yearly Net Income VS EBIT VS OCF VS FCFIMMR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M

1.2 Ratios

IMMR's Return On Assets of 2.86% is fine compared to the rest of the industry. IMMR outperforms 65.71% of its industry peers.
IMMR has a Return On Equity of 14.75%. This is amongst the best in the industry. IMMR outperforms 82.86% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.89%, IMMR is in line with its industry, outperforming 57.14% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for IMMR is significantly below the industry average of 15.32%.
The last Return On Invested Capital (1.89%) for IMMR is well below the 3 year average (9.10%), which needs to be investigated, but indicates that IMMR had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.86%
ROE 14.75%
ROIC 1.89%
ROA(3y)13%
ROA(5y)5.72%
ROE(3y)15.61%
ROE(5y)6.28%
ROIC(3y)9.1%
ROIC(5y)N/A
IMMR Yearly ROA, ROE, ROICIMMR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

1.3 Margins

IMMR's Profit Margin of 100.17% is amongst the best of the industry. IMMR outperforms 97.14% of its industry peers.
In the last couple of years the Profit Margin of IMMR has grown nicely.
With an excellent Operating Margin value of 52.85%, IMMR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of IMMR has grown nicely.
Industry RankSector Rank
OM 52.85%
PM (TTM) 100.17%
GM N/A
OM growth 3Y94.23%
OM growth 5Y2.01%
PM growth 3Y78.19%
PM growth 5Y15.41%
GM growth 3YN/A
GM growth 5YN/A
IMMR Yearly Profit, Operating, Gross MarginsIMMR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100 -100

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IMMR is still creating some value.
IMMR has less shares outstanding than it did 1 year ago.
IMMR has more shares outstanding than it did 5 years ago.
IMMR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IMMR Yearly Shares OutstandingIMMR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
IMMR Yearly Total Debt VS Total AssetsIMMR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of 0.55, we must say that IMMR is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of IMMR (0.55) is worse than 65.71% of its industry peers.
A Debt/Equity ratio of 0.81 indicates that IMMR is somewhat dependend on debt financing.
IMMR's Debt to Equity ratio of 0.81 is in line compared to the rest of the industry. IMMR outperforms 42.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Altman-Z 0.55
ROIC/WACC0.22
WACC8.78%
IMMR Yearly LT Debt VS Equity VS FCFIMMR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.55 indicates that IMMR should not have too much problems paying its short term obligations.
With a Current ratio value of 1.55, IMMR perfoms like the industry average, outperforming 54.29% of the companies in the same industry.
IMMR has a Quick Ratio of 1.55. This is a bad value and indicates that IMMR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of IMMR (0.72) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 0.72
IMMR Yearly Current Assets VS Current LiabilitesIMMR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

5

3. Growth

3.1 Past

IMMR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.12%, which is quite good.
Measured over the past years, IMMR shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.60% on average per year.
IMMR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.81%.
Measured over the past years, IMMR shows a very negative growth in Revenue. The Revenue has been decreasing by -21.11% on average per year.
EPS 1Y (TTM)14.12%
EPS 3Y47.44%
EPS 5Y-9.6%
EPS Q2Q%N/A
Revenue 1Y (TTM)-11.81%
Revenue growth 3Y3.61%
Revenue growth 5Y-21.11%
Sales Q2Q%-22.96%

3.2 Future

Based on estimates for the next years, IMMR will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.87% on average per year.
The Revenue is expected to grow by 189.84% on average over the next years. This is a very strong growth
EPS Next Y75.07%
EPS Next 2Y62.1%
EPS Next 3Y10.87%
EPS Next 5YN/A
Revenue Next Year1039.86%
Revenue Next 2Y388.92%
Revenue Next 3Y189.84%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IMMR Yearly Revenue VS EstimatesIMMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
IMMR Yearly EPS VS EstimatesIMMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2 3

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 5.46, which indicates a rather cheap valuation of IMMR.
Compared to the rest of the industry, the Price/Earnings ratio of IMMR indicates a rather cheap valuation: IMMR is cheaper than 97.14% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of IMMR to the average of the S&P500 Index (26.46), we can say IMMR is valued rather cheaply.
IMMR is valuated cheaply with a Price/Forward Earnings ratio of 2.08.
Based on the Price/Forward Earnings ratio, IMMR is valued cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.10, IMMR is valued rather cheaply.
Industry RankSector Rank
PE 5.46
Fwd PE 2.08
IMMR Price Earnings VS Forward Price EarningsIMMR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IMMR indicates a somewhat cheap valuation: IMMR is cheaper than 77.14% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.5
IMMR Per share dataIMMR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IMMR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.07
PEG (5Y)N/A
EPS Next 2Y62.1%
EPS Next 3Y10.87%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.64%, IMMR has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.92, IMMR pays a better dividend. On top of this IMMR pays more dividend than 94.29% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, IMMR has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.64%

5.2 History

IMMR has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
IMMR Yearly Dividends per shareIMMR Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

DPN/A
EPS Next 2Y62.1%
EPS Next 3Y10.87%
IMMR Yearly Income VS Free CF VS DividendIMMR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M

IMMERSION CORPORATION

NASDAQ:IMMR (12/5/2025, 8:00:01 PM)

After market: 6.82 0 (0%)

6.82

+0.01 (+0.15%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)10-01 2025-10-01
Earnings (Next)N/A N/A
Inst Owners34.19%
Inst Owner Change-7.5%
Ins Owners3.34%
Ins Owner Change-2.5%
Market Cap341.20M
Revenue(TTM)33.92M
Net Income(TTM)33.98M
Analysts82.86
Price Target12.5 (83.28%)
Short Float %6.68%
Short Ratio6.39
Dividend
Industry RankSector Rank
Dividend Yield 2.64%
Yearly Dividend0.23
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date10-20 2025-10-20 (0.045)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 5.46
Fwd PE 2.08
P/S 10.06
P/FCF N/A
P/OCF N/A
P/B 1.48
P/tB 2.81
EV/EBITDA 16.5
EPS(TTM)1.25
EY18.33%
EPS(NY)3.28
Fwd EY48.16%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.68
BVpS4.6
TBVpS2.42
PEG (NY)0.07
PEG (5Y)N/A
Graham Number11.38
Profitability
Industry RankSector Rank
ROA 2.86%
ROE 14.75%
ROCE 2.39%
ROIC 1.89%
ROICexc 2.3%
ROICexgc 2.8%
OM 52.85%
PM (TTM) 100.17%
GM N/A
FCFM N/A
ROA(3y)13%
ROA(5y)5.72%
ROE(3y)15.61%
ROE(5y)6.28%
ROIC(3y)9.1%
ROIC(5y)N/A
ROICexc(3y)48.9%
ROICexc(5y)N/A
ROICexgc(3y)48.9%
ROICexgc(5y)N/A
ROCE(3y)11.5%
ROCE(5y)N/A
ROICexgc growth 3Y84.52%
ROICexgc growth 5YN/A
ROICexc growth 3Y84.52%
ROICexc growth 5Y-44.16%
OM growth 3Y94.23%
OM growth 5Y2.01%
PM growth 3Y78.19%
PM growth 5Y15.41%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Debt/EBITDA 10.37
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 0.72
Altman-Z 0.55
F-ScoreN/A
WACC8.78%
ROIC/WACC0.22
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)109.51%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.12%
EPS 3Y47.44%
EPS 5Y-9.6%
EPS Q2Q%N/A
EPS Next Y75.07%
EPS Next 2Y62.1%
EPS Next 3Y10.87%
EPS Next 5YN/A
Revenue 1Y (TTM)-11.81%
Revenue growth 3Y3.61%
Revenue growth 5Y-21.11%
Sales Q2Q%-22.96%
Revenue Next Year1039.86%
Revenue Next 2Y388.92%
Revenue Next 3Y189.84%
Revenue Next 5YN/A
EBIT growth 1Y-26.59%
EBIT growth 3Y101.23%
EBIT growth 5Y-19.52%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-48.65%
FCF growth 3YN/A
FCF growth 5Y-21.67%
OCF growth 1Y-48.69%
OCF growth 3Y909.9%
OCF growth 5Y-21.68%

IMMERSION CORPORATION / IMMR FAQ

Can you provide the ChartMill fundamental rating for IMMERSION CORPORATION?

ChartMill assigns a fundamental rating of 5 / 10 to IMMR.


What is the valuation status of IMMERSION CORPORATION (IMMR) stock?

ChartMill assigns a valuation rating of 7 / 10 to IMMERSION CORPORATION (IMMR). This can be considered as Undervalued.


How profitable is IMMERSION CORPORATION (IMMR) stock?

IMMERSION CORPORATION (IMMR) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for IMMR stock?

The Price/Earnings (PE) ratio for IMMERSION CORPORATION (IMMR) is 5.46 and the Price/Book (PB) ratio is 1.48.